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Abstract
In our report we would like to present a case of a 60-year-old patient with
epileptic seizures, affective disturbances, only mild neurocognitive disorders
and cardiomyopathy. A female patient was taken to the internal ward with
a tentative diagnosis of recurrent syncope. Laboratory results disclosed severe
hypocalcaemia, hypoparathyroidism, and hypothyroidism. An echocardiogram
revealed left ventricle systolic dysfunction. Computed tomography revealed
massive intracranial calcifications typical for Fahr’s syndrome. Our patient
demonstrated only mild neurological and psychiatric symptoms, but developed
hypocalcaemic heart failure. It is possible that some cases of Fahr’s syndrome
remain undiscovered, particularly patients taken to internal wards with mild
neurological or psychiatric signs.
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Introduction
Fahr’s syndrome, also called bilateral striatopallidodentate calcinosis
(BSPDC), is a disease characterized by symmetric, non-atherosclerotic
calcification of the basal ganglia. Both familial and sporadic cases have
been previously reported. A locus on chromosome 14q has been identified
as associated with BSPDC [1]. Familial type of the syndrome has been
previously described [2]. However, it has also been reported that BSPDC
is not linked to the IBGC1 locus on chromosome 14q [3]. Calcium deposits
are the major element responsible for the radiological appearance of the
disease. Hypoparathyroidism and disturbance of calcium metabolism can
be responsible for BSPDC development, but cases of patients with normal
parathormone  levels  have  also  been  reported  [4].  Pseudohypo-
parathyroidism associated with production of biologically inactive form of
parathormone can also be connected with BSPDC pathology. It is possible
that disturbance of blood flow through basal ganglia associated with
arterial  malformations  cause  injury  to  the  blood-brain  barrier.
A consequence of this may be precipitation and mineralization of serum
proteins. Alkaline phosphatase (AP), which plays a role in cellular transport,
may also be involved in pathogenesis of BSPDC; increase in AP activity in
basal ganglia was observed in patients, while serum AP activity remained
beyond normal values. Progressive inflammatory processes in the brain
may also be responsible for calcifications [5]. Clinical symptoms of BSPDC
are found in the literature as case reports, because the disease is very rare.
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The  most  common  symptom  of  BSPDC  is
considered  to  be  movement  disorders,  both
Parkinsonism and hyperkinetic movement disorders
(chorea,  tremor,  dystonia,  athetosis,  oro-facial
dyskinesia).  The  second  most  common  mani-
festation of BSPDC is cognitive impairment followed
by cerebellar impairment and speech disorder.
Psychiatric features (dementia, psychosis, affective
disturbances), gait disorders, and sensory changes
are also reported. Neurological disorders such as
extrapyramidal symptoms, pyramidal symptoms,
epileptic  seizures,  choreoathetosis,  and  glos-
sopharyngeal neuralgia may also be associated with
BSPDC. Diagnosis of BSPDC is based on finding
pathognomonic  basal  ganglia  calcifications  in
computed tomography or magnetic resonance
imaging [6].
Case report
We would like to report the case of a 60-year-
old  patient  with  epileptic  seizures,  affective
disturbances, only mild neurocognitive disorders
and cardiomyopathy. A female patient was taken
to the internal ward with a tentative diagnosis of
recurrent syncope. On admission she gave a history
of hypertension, worsening of exercise tolerance,
and oedema of the lower extremities. The patient
also  reported  depressive  mood  and  memory
deterioration.  The  patient  reported  that  both
physical and psychiatric symptoms had developed
for the last twelve months. There was no history of
alcohol abuse, nicotinism, previous surgery or family
history of similar illness. On admission she was alert
and  cooperative.  Physical  examination  of  the
respiratory system, heart and abdomen did not
reveal anything specific. Bilateral oedema of the
lower limbs was present. An ECG examination taken
on admission revealed flattened T-waves in limb
leads, biphasic T-waves in precordial leads V3-V5
and prolonged QTc interval (531 ms) (Figures 1A-D).
Laboratory  results  disclosed  the  following
abnormalities:  hypocalcaemia,  hyperphospha-
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taemia,  hypoparathyroidism,  hypothyroidism,
increased  thyroid  peroxidase  antibodies  and
thyroglobulin antibodies (Table I). A transthoracic
echocardiogram revealed generalized hypokinesis
of  the  left  ventricle  and  systolic  dysfunction
(reduced ejection fraction: EF = 42%). ECG Holter
monitoring did not reveal any abnormalities which
could be responsible for the recurrent syncope. No
abnormalities  of  the  ST  segment  typical  for
ischaemic heart disease were present in ECG Holter
monitoring. Computed tomography (Figures 2-5)
revealed bilateral, massive calcifications of the
cerebellar  dentate  nucleus  and  white  matter,
lenticular nucleus: putamen and globus pallidus,
caudate nucleus, thalamus, pons, white matter of
centrum semiovale, grey matter of the fundus of
fissures in the frontal lobe (superior frontal sulcus),
parietal  lobe  (central  sulcus),  temporal  lobe
(superior  temporal  sulcus),  and  occipital  lobe
(calcarine sulcus and parieto-occipital fissure).
Electroencephalography  did  not  show  any
abnormalities. Psychiatric examination revealed
depression,  anxiety  and  mild  neurocognitive
impairment (Mini-Mental State Examination: 23
points – MMSE) [7]. The patient reported depressive
mood, apathy, and inability to make decisions, that
had developed since one year ago. Finally she was
too apathetic to perform daily living activities. Three
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S Se er ru um m   p pa ar ra am me et te er r P Pa at ti ie en nt t’ ’s s   r re es su ul lt t L La ab bo or ra at to or ry y   n no or rm m
Calcium 3.61 mg/dl 8.5-10.8 mg/dl
Phosphate 7.3 mg/dl 2.4-4.5 mg/dl
Parathormone 3.39 pg/mol 10.0-70.0 pg/mol
Thyrotropin 12.39 ﾵU/ml 0.27-4.2 ﾵU/ml
Triiodothyronine 3.38 pmol/l 3.1-6.8 pmol/l
Thyroxine 8.52 pmol/l 12.0-22.0 pmol/l
Thyroid peroxidase  > 600 U/ml 0.0-34.0 U/ml
antibodies (TPOAb)
Thyroglobulin  600.8 IU/ml 0.0-115.0 IU/ml
antibodies (TgAb)
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and  ten  days  after  admission  episodes  of
unconsciousness  were  observed  by  medical
professionals. Each episode lasted circa 15 min;
involuntary passing of urine was noted. The patient
reported that episodes of unconsciousness had
occurred about once a month during the last year.
Each  episode  lasted  10-20  min.  In  some  cases
involuntary passing of urine was observed. Witnesses
of  these  episodes  related  that  after  regaining
consciousness, the patient’s consciousness was
clouded for about 30 min. Typical epileptic seizures
were not observed. ECG examination performed
during an episode of unconsciousness did not reveal
any  abnormalities.  Ultimately,  the  patient  was
diagnosed as having BSPDC and hypocalcaemic heart
failure related to idiopathic hypoparathyroidism.
Initially,  the  symptoms  of  hypocalcaemia  were
controlled  with  calcium  gluconate  infusion;
subsequently oral calcium carbonate and α-calcidol
were started. Pharmacotherapy of heart failure 
with  losartan,  bisoprolol,  spironolactone  and
hydrochlorothiazide was administered. An additional
treatment with thyroxine, valproic acid and sertraline
was also instituted. Restoration of normocalcaemia
resulted in full clinical improvement of cardiac
function  in  two  weeks.  Improvement  in  echo-
cardiogram was also noted: signs of left ventricle
hypokinesis retreated and EF increased up to 52%.
Attacks  of  unconsciousness  responded  well  to
valproic acid therapy. 
Telephone contact with the patient’s husband
made three months after discharge from hospital
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confirmed that these attacks had not occurred,
exercise tolerance had improved, and oedema of
the lower extremities was not present. However,
the  patient’s  husband  observed  gradual
deterioration of neurocognitive functions.
Discussion
In this case of BSPDC, attacks of unconscious-
ness  were  the  predominant  neurological
manifestation.  Our  patient  also  presented
hypocalcaemic cardiomyopathy. There are case
reports presenting cases of reversible hypocalcaemic
cardiomyopathy [8-11]. Long-lasting hypocalcaemia
may result in cardiac dysfunction. Having in mind
that laboratory results disclosed hypothyroidism
(caused by autoimmune processes – antithyroid
antibodies) it may be possible that this condition is
partially  responsible  for  cardiomyopathy.
Hypothyroidism  may  cause  both  systolic  and
diastolic dysfunction. In our patient only systolic
dysfunction  was  noted,  which  seems  to  be
connected with calcium deficiency. Restoration of
a normal calcium level resulted in clinical and
echocardiographic improvement in two weeks. We
conclude  that  two  weeks  time  was  too  short
a period to restore hormonal balance although
thyroxine was added to the treatment regimen. The
patient did not consent to coronary angiography,
so we cannot rule out atherosclerosis and ischaemic
heart disease. However, the patient did not give
a history  of  retrosternal  pain  or  any  other
symptoms  that  could  suggest  coronary  artery
disease.  The  laboratory  findings  and  massive
intracranial calcifications suggesting long-standing
hypocalcaemia  confirm  our  theory.  Calcium  is
necessary  for  myocardial  contractile  function.
Parathormone has a positive inotropic effect on the
heart muscle that is mediated by increasing the
entry of calcium into myocardial cells and the
release of endogenous myocardial norepinephrine
[12]. Myocardial sarcoplasmic reticulum is not able
to sequestrate a sufficient quantity of calcium to
initiate contraction. The strength of myocardial
contraction is associated with extracellular calcium
influx. It has also been proposed that a decrease of
calcium levels in renal tubular cells may increase
renal sodium reabsorption and via this mechanism
promote sodium retention and the development of
cardiac failure [10]. The role of calcium in the
therapy of cardiac failure should be kept in mind as
loop diuretics such as furosemide or torasemide
may induce hypocalcaemia even in patients with
normal parathormone levels. If congestive heart
failure does not respond to conventional anti-failure
therapy,  hypocalcaemia  should  be  taken  into
consideration. Therefore, the idea of calcium level
determination in all patients with heart failure
suggested in previous reports [10, 11] is supported
by us. It is possible that patients with asymptomatic
hypocalcaemia and heart failure treated with high
doses  of  loop  diuretics  may  develop  severe
hypocalcaemia and their state may deteriorate.
Such a case has been previously reported [9].
In conclusion, patients with BSPDC can present
a variety of symptoms. BSPDC cases are reported
mainly by psychiatrists or neurologists. Our patient
demonstrated  only  mild  neurological  and
psychiatric symptoms but developed hypocalcaemic
heart failure. Having in mind that cardiomyopathy
associated with hypocalcaemia is reversible, we
should determine the calcium level in all subjects
with heart failure.
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